The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart
出版年份 2021 全文链接
标题
The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 12, Pages 6627
出版商
MDPI AG
发表日期
2021-06-22
DOI
10.3390/ijms22126627
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Lumenal calcification and microvasculopathy in fetuin-A-deficient mice lead to multiple organ morbidity
- (2020) Marietta Herrmann et al. PLoS One
- History of Nonalcoholic Fatty Liver Disease
- (2020) Amedeo Lonardo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans
- (2018) Andreas Peter et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease
- (2018) V. Pampanini et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
- (2017) Ruth C. R. Meex et al. Nature Reviews Endocrinology
- Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population
- (2017) Zhengsen Cui et al. Oncotarget
- Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis
- (2016) Sarah A. Aroner et al. ATHEROSCLEROSIS
- Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
- (2016) Romina Lomonaco et al. DIABETES CARE
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
- (2016) Hermann Toplak et al. DIABETOLOGIA
- Nonalcoholic Fatty Liver Disease
- (2016) Fernando Bril et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD
- (2016) Fernando Bril et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease
- (2016) C. von Loeffelholz et al. JOURNAL OF INVESTIGATIVE SURGERY
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease
- (2015) Ya Huang et al. MEDICINE
- Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease
- (2015) Cemal Nuri Ercin et al. Metabolic Syndrome and Related Disorders
- Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery
- (2015) Michael Subichin et al. Surgery for Obesity and Related Diseases
- The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease
- (2015) Gurkan Celebi et al. Saudi Journal of Gastroenterology
- Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease
- (2014) Dariusz M. Lebensztejn et al. Advances in Medical Sciences
- Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance
- (2014) Raffaela Rametta et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Fetuin-A: a novel link between obesity and related complications
- (2014) J F Trepanowski et al. INTERNATIONAL JOURNAL OF OBESITY
- Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects
- (2014) Motoya Sato et al. LIVER INTERNATIONAL
- Ectopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
- (2014) Gerald I. Shulman NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Levels of Fetuin‐A and Risk of Coronary Heart Disease in US Women: The Nurses' Health Study
- (2014) Qi Sun et al. Journal of the American Heart Association
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
- (2014) Hannele Yki-Järvinen Lancet Diabetes & Endocrinology
- Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
- (2014) Akira Sasaki et al. Frontiers in Endocrinology
- Fetuin-A (α2HS-glycoprotein) is a serum chemo-attractant that also promotes invasion of tumor cells through Matrigel
- (2013) Gladys N. Nangami et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes
- (2013) Zi-Wen Zhao et al. BIOMARKERS
- Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients
- (2013) Alisan Kahraman et al. CLINICAL SCIENCE
- Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2013) Maria Stepanova et al. DIGESTIVE DISEASES AND SCIENCES
- Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis
- (2013) Fernando Bril et al. HEPATOLOGY
- Extrahepatic complications of nonalcoholic fatty liver disease
- (2013) Matthew J. Armstrong et al. HEPATOLOGY
- Relationship of Serum Fetuin-A Levels with Coronary Atherosclerotic Burden and NAFLD in Patients Undergoing Elective Coronary Angiography
- (2013) Stefano Ballestri et al. Metabolic Syndrome and Related Disorders
- The role of hepatokines in metabolism
- (2013) Norbert Stefan et al. Nature Reviews Endocrinology
- Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease
- (2012) Teoman Dogru et al. CLINICAL ENDOCRINOLOGY
- Fetuin-A, Type 2 Diabetes, and Risk of Cardiovascular Disease in Older Adults: The Cardiovascular Health Study
- (2012) M. K. Jensen et al. DIABETES CARE
- Endoplasmic Reticulum Stress Induces the Expression of Fetuin-A to Develop Insulin Resistance
- (2012) Horng-Yih Ou et al. ENDOCRINOLOGY
- Increased Fetuin-A Concentrations in Impaired Glucose Tolerance with or without Nonalcoholic Fatty Liver Disease, But Not Impaired Fasting Glucose
- (2012) Horng-Yih Ou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Association of Fetuin-A With Cardiovascular Disease Mortality in Older Community-Dwelling Adults
- (2012) Gail A. Laughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes
- (2011) Horng-Yih Ou et al. CLINICAL ENDOCRINOLOGY
- Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction
- (2011) Krisztián Vörös et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
- (2011) John Willy Haukeland et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss
- (2010) Johanna Maria Brix et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4
- (2010) M. L. Ford et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serum fetuin A/ 2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis
- (2010) Y. Yilmaz et al. ANNALS OF CLINICAL BIOCHEMISTRY
- NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study
- (2009) Leon A Adams et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- High Prevalence of Coronary Heart Disease in Type 2 Diabetic Patients with Non-alcoholic Fatty Liver Disease
- (2009) Hongyun Lu et al. ARCHIVES OF MEDICAL RESEARCH
- Extended-release niacin decreases serum fetuin-A concentrations in individuals with metabolic syndrome
- (2009) Shalini V. Kaushik et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Decreased survival of subjects with elevated liver function tests during a 28-year follow-up
- (2009) Cecilia Söderberg et al. HEPATOLOGY
- Fetuin-A Protects against Atherosclerotic Calcification in CKD
- (2009) R. Westenfeld et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure
- (2009) Isao Matsui et al. KIDNEY INTERNATIONAL
- Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke
- (2008) Cornelia Weikert et al. CIRCULATION
- Fetuin-A and Its Relation to Metabolic Syndrome and Fatty Liver Disease in Obese Children Before and After Weight Loss
- (2008) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum Fetuin-A Concentration and Endothelial Dysfunction in Chronic Kidney Disease
- (2008) Kayser Caglar et al. NEPHRON CLINICAL PRACTICE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started